ArticleOpen research Europe2022

Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review (protocol).

Leire Leache et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.